EP1904081A4 - COMPOSITIONS AND METHODS FOR CONTROLLING AN ANGIOGENESIS WITH CUPREDOXINES - Google Patents

COMPOSITIONS AND METHODS FOR CONTROLLING AN ANGIOGENESIS WITH CUPREDOXINES

Info

Publication number
EP1904081A4
EP1904081A4 EP06787787A EP06787787A EP1904081A4 EP 1904081 A4 EP1904081 A4 EP 1904081A4 EP 06787787 A EP06787787 A EP 06787787A EP 06787787 A EP06787787 A EP 06787787A EP 1904081 A4 EP1904081 A4 EP 1904081A4
Authority
EP
European Patent Office
Prior art keywords
cupredoxins
compositions
methods
controlling angiogenesis
angiogenesis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP06787787A
Other languages
German (de)
English (en)
French (fr)
Other versions
EP1904081A2 (en
Inventor
Rajeshwari Mehta
Brad Taylor
Tohru Yamada
Craig Beattie
Tapas Das Gupta
Ananda Chakrabarty
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Illinois at Urbana-Champaign
University of Illinois System
Original Assignee
University of Illinois at Urbana-Champaign
University of Illinois System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/244,105 external-priority patent/US7691383B2/en
Priority claimed from US11/436,592 external-priority patent/US7381701B2/en
Application filed by University of Illinois at Urbana-Champaign, University of Illinois System filed Critical University of Illinois at Urbana-Champaign
Publication of EP1904081A2 publication Critical patent/EP1904081A2/en
Publication of EP1904081A4 publication Critical patent/EP1904081A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/415—Assays involving biological materials from specific organisms or of a specific nature from plants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Cardiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
EP06787787A 2005-07-19 2006-07-19 COMPOSITIONS AND METHODS FOR CONTROLLING AN ANGIOGENESIS WITH CUPREDOXINES Withdrawn EP1904081A4 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US70029705P 2005-07-19 2005-07-19
US11/244,105 US7691383B2 (en) 2004-10-07 2005-10-06 Cupredoxin derived transport agents and methods of use thereof
US76474906P 2006-02-03 2006-02-03
US11/436,592 US7381701B2 (en) 2001-02-15 2006-05-19 Compositions and methods for treating conditions related to ephrin signaling with cupredoxins
PCT/US2006/027940 WO2007024368A2 (en) 2005-07-19 2006-07-19 Compositions and methods to control angiogenesis with cupredoxins

Publications (2)

Publication Number Publication Date
EP1904081A2 EP1904081A2 (en) 2008-04-02
EP1904081A4 true EP1904081A4 (en) 2008-12-03

Family

ID=37772089

Family Applications (1)

Application Number Title Priority Date Filing Date
EP06787787A Withdrawn EP1904081A4 (en) 2005-07-19 2006-07-19 COMPOSITIONS AND METHODS FOR CONTROLLING AN ANGIOGENESIS WITH CUPREDOXINES

Country Status (10)

Country Link
EP (1) EP1904081A4 (cg-RX-API-DMAC7.html)
JP (1) JP2009502797A (cg-RX-API-DMAC7.html)
KR (1) KR20080034905A (cg-RX-API-DMAC7.html)
AU (1) AU2006284490A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0615555A2 (cg-RX-API-DMAC7.html)
CA (1) CA2615560A1 (cg-RX-API-DMAC7.html)
IL (1) IL188691A0 (cg-RX-API-DMAC7.html)
MX (1) MX2008000993A (cg-RX-API-DMAC7.html)
NO (1) NO20080829L (cg-RX-API-DMAC7.html)
WO (1) WO2007024368A2 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8158574B2 (en) * 2004-10-07 2012-04-17 Cdg Therapeutics, Inc. Compositions and methods to prevent cancer with cupredoxins
EP2061498A4 (en) * 2006-09-14 2009-11-04 Univ Illinois COMPOSITIONS AND METHOD FOR CANCER PREPARATION WITH CUPREDOXINES
AU2007329375A1 (en) 2006-12-04 2008-06-12 The Board Of Trustees Of The University Of Illinois Compositions and methods to treat cancer with cupredoxins and CpG rich DNA

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005018662A1 (en) * 2003-08-15 2005-03-03 Board Of Trustees Of The University Of Illinois Use of polypeptides of the cupredoxin family in cancer therapy
WO2006088508A2 (en) * 2004-10-07 2006-08-24 Ananda Chakrabarty Cupredoxin derived transport agents and methods of use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006277009A1 (en) * 2005-05-20 2007-02-15 The Board Of Trustees Of The University Of Illinois Compositions and methods for treating conditions related to ephrin signaling with cupredoxins
JP2008545398A (ja) * 2005-05-20 2008-12-18 ザ・ボード・オブ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・イリノイ キュプレドキシンおよびシトクロムcを用いてhiv感染を治療するための組成物および方法
AU2006251742A1 (en) * 2005-05-20 2006-11-30 The Board Of Trustees Of The University Of Illinois Compositions and methods for treating malaria with cupredoxin and cytochrome

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005018662A1 (en) * 2003-08-15 2005-03-03 Board Of Trustees Of The University Of Illinois Use of polypeptides of the cupredoxin family in cancer therapy
WO2006088508A2 (en) * 2004-10-07 2006-08-24 Ananda Chakrabarty Cupredoxin derived transport agents and methods of use thereof

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE GENESEQ [online] DERWENT PUBLICATIONS LTD., LONDON, GB; 23 June 2004 (2004-06-23), XU R. ET AL: "Azurin as bacterial protein with wide spectrum antitumor function and its use and medical composition", XP002499408, retrieved from EBI Database accession no. ADV69505 *
DATABASE UNIPROT [online] 21 July 1986 (1986-07-21), "RecName: Full=Azurin; Flags: Precursor;", retrieved from EBI accession no. UNIPROT:P00282 Database accession no. P00282 *
YAMADA TOHRU; FIALHO ARSENIO M; PUNJ VASU; BRATESCU LAURA; DAS GUPTA TAPAS K; CHAKRABARTY ANANDA M: "Internalization of bacterial redox protein azurin in mammalian cells: entry domain and specificity", CELLULAR MICROBIOLOGY, vol. 7, no. 10, 5 July 2005 (2005-07-05) - 25 October 2005 (2005-10-25), pages 1418 - 1431, XP002499203 *

Also Published As

Publication number Publication date
WO2007024368A3 (en) 2007-10-11
WO2007024368A2 (en) 2007-03-01
IL188691A0 (en) 2008-08-07
AU2006284490A8 (en) 2008-02-28
KR20080034905A (ko) 2008-04-22
NO20080829L (no) 2008-04-02
EP1904081A2 (en) 2008-04-02
CA2615560A1 (en) 2007-03-01
AU2006284490A1 (en) 2007-03-01
BRPI0615555A2 (pt) 2009-07-14
MX2008000993A (es) 2008-03-19
JP2009502797A (ja) 2009-01-29

Similar Documents

Publication Publication Date Title
BRPI0613033A2 (pt) composição oral
EP1732906A4 (en) 2-AMINOTHIAZONE COMPOUNDS SUITABLE AS ASPARTYL PROTEASE INHIBITORS
PL1896063T3 (pl) Kompozycja immunogenna
DE602004009780D1 (de) Neue strahlenhärtbare Zusammensetzungen
ITMI20041252A1 (it) Composizioni perfluoroelastomeriche
EP1788047A4 (en) WATER REPELLENT / OIL-REPELLING COMPOSITION
EP1844189A4 (en) PROBENAHMEMOPP
DE602006012777D1 (de) Horizontale Niederspannvorrichtung
EP1839669A4 (en) NEW ANGIOGENESEHEMMER
DE602005005064D1 (de) Neue 4-benzylidenpiperidinderivate
DE602004008217D1 (de) Einfach dispergierbare konzentrierte Esterquat Zusammensetzungen
GB0414594D0 (en) Aqueous composition 1
DE602004008602D1 (de) Neue strahlenhärtbare Zusammensetzungen
DE602005017191D1 (de) Geruchsreduzierte waschstück-zusammensetzung
EP1854467A4 (en) COMPOSITION FOR IMMUNACTIVATION
ATE425167T1 (de) Neue pyridothienopyrimidinderivate
ZA200804391B (en) Novel vinylogous acids derivatives
DE602006020013D1 (de) EGPWS-Klappenpositionsverbesserung
FR2871686B1 (fr) Composition anti-decoloration
ITMI20041447A1 (it) Composizione farmaceutica comprendente gabapentina
ATE445604T1 (de) Neue 2,6-diaminopyridin-3-on-derivate
NO20050614L (no) Refractory compositions
ITBO20050074U1 (it) Manufatto per l'edilizia
FR2880793B1 (fr) Prothese d'epaule
NO20042027D0 (no) Oral composition

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20080117

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR MK YU

RAX Requested extension states of the european patent have changed

Extension state: RS

Extension state: MK

Extension state: HR

Extension state: BA

Extension state: AL

A4 Supplementary search report drawn up and despatched

Effective date: 20081105

17Q First examination report despatched

Effective date: 20090219

DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20121009